BICAN launches first major data release

The BRAIN Initiative® Cell Atlas Network (BICAN) has launched its first major data release, marking a significant milestone in the ambitious effort to map the whole human brain.

Bristol Myers’ subcutaneous version of Opdivo gets earlier PDUFA date

The FDA has shortened the timeline for coming to a decision on Bristol Myers Squibb’s subcutaneous version of its blockbuster PD-1 inhibitor Opdivo. The company

May 22, 2024

SOCIETAL CDMO ANNOUNCES PRICING OF $8.3 MILLION PUBLIC OFFERING OF COMMON STOCK | Psychedelic Invest

Societal CDMO, Inc. (“Societal”; NASDAQ: SCTL), a contract development and manufacturing organization (“CDMO”) dedicated to solving complex formulation and manufacturing challenges primarily in small molecule

August 24, 2023

Better Therapeutics wins breakthrough status for health app to treat liver disease

Listen to the article 4 min This audio is auto-generated. Please let us know if you have feedback. Dive Brief: Better Therapeutics has received breakthrough

February 22, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.